A1 Journal article – refereed
Radiation Dosimetry and Biodistribution of the Hypoxia Tracer F-18-EF5 in Oncologic Patients




List of Authors: Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Gronroos TJ, Forsback S, Evans SM, Koch CJ, Minn H
Publisher: MARY ANN LIEBERT INC
Publication year: 2012
Journal: Cancer Biotherapy and Radiopharmaceuticals
Journal name in source: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Journal acronym: CANCER BIOTHER RADIO
Number in series: 7
Volume number: 27
Issue number: 7
Number of pages: 8
ISSN: 1084-9785

Abstract


Conclusions: F-18-EF5 was demonstrated to be safe for patients, and the radiation exposure is clinically acceptable. As with any radiotracer with primary excretion in the urine, the bladder-wall dose can be minimized by active hydration and frequent voiding.



Last updated on 2019-21-08 at 22:44